Literature DB >> 2749844

First-year results of a community-based study of stroke incidence in Umbria, Italy.

S Ricci1, M G Celani, G Guercini, P Rucireta, R Vitali, F La Rosa, E Duca, R Ferraguzzi, M Paolotti, D Seppoloni.   

Abstract

The SEPIVAC study (Italian initials for "epidemiologic study of incidence of acute cerebrovascular disease") is a community-based epidemiologic survey of incidence and outcome of cerebrovascular disease in the territory of the 6th Local Health Unit, Umbria, Italy, where 49,101 people live. All cases were registered with the study either by notification from general practitioners or by check of hospital admission within the study area and in the two hospitals of Perugia. Death certificates were looked at as well. Patients were registered with the study when the clinical picture fulfilled the definition of stroke and transient ischemic attack (TIA) adopted for this study. Patients were followed up at approximately 30 days and 6 months. During the first year of the study (September 1, 1986 to August 31, 1987), 189 cases were registered: 108 suffered a "first ever in a lifetime" stroke, 30 a recurrent stroke, and 51 a "first ever in a lifetime" transient ischemic attack. Sixty-one percent of patients (71% of first strokes) had a computed tomography scan. For our study, the crude annual incidence rate of first stroke was 2.2 per 1,000 (confidence intervals 1.81-2.66); the standardized rate to the European population was 1.36 (confidence intervals 1.06-1.74). At least 83% of first strokes were due to cerebral ischemia; in 26 cases a clinical diagnosis of lacunar ischemia was made. The 30-day case fatality rate was 21%; 25% of our patients had recovered completely or almost completely after 1 month.

Entities:  

Mesh:

Year:  1989        PMID: 2749844     DOI: 10.1161/01.str.20.7.853

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  9 in total

1.  Intra-arterial thrombolysis.

Authors: 
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

2.  Was it infarction or haemorrhage? A clinical diagnosis by means of the Allen score.

Authors:  M G Celani; M G Ceravolo; E Duca; P Minciotti; N Caputo; M Orlandini; S Ricci; L Provinciali
Journal:  J Neurol       Date:  1992-08       Impact factor: 4.849

Review 3.  Medicine in the elderly.

Authors:  P Diggory; A Homer; J Liddle; C F Pratt; S Samadian; R Tozer; C Weinstein
Journal:  Postgrad Med J       Date:  1991-05       Impact factor: 2.401

4.  Hemianopia, hemianaesthesia, and hemiplegia after right and left hemisphere damage. A hemispheric difference.

Authors:  R Sterzi; G Bottini; M G Celani; E Righetti; M Lamassa; S Ricci; G Vallar
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-03       Impact factor: 10.154

Review 5.  Cost-effective intervention in stroke.

Authors:  D Dunbabin
Journal:  Pharmacoeconomics       Date:  1992-12       Impact factor: 4.981

6.  SEPIVAC: a community-based study of stroke incidence in Umbria, Italy.

Authors:  S Ricci; M G Celani; F La Rosa; R Vitali; E Duca; R Ferraguzzi; M Paolotti; D Seppoloni; N Caputo; C Chiurulla
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-08       Impact factor: 10.154

7.  A community-based study of incidence, risk factors and outcome of transient ischaemic attacks in Umbria, Italy: the SEPIVAC study.

Authors:  S Ricci; M G Celani; F La Rosa; R Vitali; E Duca; R Ferraguzzi; M Paolotti; D Seppoloni; N Caputo; C Chiurulla
Journal:  J Neurol       Date:  1991-04       Impact factor: 4.849

8.  Atrial fibrillation and stroke: prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire community stroke project)

Authors:  P Sandercock; J Bamford; M Dennis; J Burn; J Slattery; L Jones; S Boonyakarnkul; C Warlow
Journal:  BMJ       Date:  1992-12-12

9.  Stroke care in the next decades: a projection derived from a community-based study in Umbria, Italy.

Authors:  F La Rosa; M G Celani; E Duca; E Righetti; G Saltalamacchia; S Ricci
Journal:  Eur J Epidemiol       Date:  1993-03       Impact factor: 8.082

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.